New treatment for eczema

Article Outline

• Copyright

A new non-steroidal cream, MAS063DP, has been developed for mild to moderate atopic dermatitis in infants and children. A multicenter trial of 142 patients aged 6 months to 12 years was recently completed and is reported in this issue of The Journal. MAS063DP is statistically more effective than vehicle cream for all the endpoints measured, and the treatment seemed to be safe and well-tolerated.